Sort
48,018 grants matching “immunotherapy”
Overcoming primary and secondary resistance in wild-type BRAF melanoma
$375,350Andrew E Aplin · Wistar Institute · P01 · FY2021 · CA
IMMUNOTHERAPY OF PSORIASIS--MECHANISM OF DAB 389
$375,340Rockefeller University · R01 · FY2000 · AI
Strategies for Receptor inhibition in immunotherapy
$375,318Kenan Christopher Garcia · Stanford University · R01 · FY2025 · CA
Quantitative and Spatially-Resolved Analysis of the Tumor Immune Contexture for Optimal Diagnosis and Treatment of Lung Cancer
$375,309Kurt A Schalper · Yale University · R37 · FY2023 · CA
Training in Immunological Mechanisms
$375,296Michael Croft · La Jolla Institute For Immunology · T32 · FY2021 · AI
Artif. Antigen Presentation to Sensitize Virus-Spec. TCells for Adoptive Immunoth
$375,263Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2009 · CA
TOWARD AN UNDERSTANDING OF CLL PROGRESSION
$375,231Carlo M Croce · Ohio State University · R01 · FY2011 · CA
Project 3 - Immune analysis of clinical trial samples
$375,182Gerald P Linette · University Of Pennsylvania · P01 · FY2018 · CA
Project 3 - Immune analysis of clinical trial samples
$375,181Gerald P Linette · University Of Pennsylvania · P01 · FY2020 · CA
Project 3 - Immune analysis of clinical trial samples
$375,181Gerald P Linette · University Of Pennsylvania · P01 · FY2021 · CA
Renal Cell Tumor-Mediated Trans-differentiation of Natural Killer Cells
$375,180Andrew Christropher Wilber · Southern Illinois University Sch Of Med · R15 · FY2013 · CA
DEFINING THE ROLE OF CELL MIGRATION IN HUMAN NK CELL DIFFERENTIATION
$375,166Emily Margaret Mace · Columbia University Health Sciences · R01 · FY2021 · AI
Targeting CCR2-expressing myeloid cells to overcome immune checkpoint inhibitor resistance in glioma
$375,159Jeffrey K Harrison · University Of Florida · R01 · FY2018 · NS
Development of murine glioblastoma model for oncolytic HSV therapy
$375,155Balveen Kaur · Augusta University · R61 · FY2025 · NS
Control of regulatory T cells by IL-17 in colorectal cancer
$375,150Kepeng Wang · University Of Connecticut Sch Of Med/Dnt · R01 · FY2025 · CA
Control of regulatory T cells by IL-17 in colorectal cancer
$375,150Kepeng Wang · University Of Connecticut Sch Of Med/Dnt · R01 · FY2021 · CA
Antigen-independent prediction and biomarker identification of cancer-specific T cells
$375,150Bo Li · Ut Southwestern Medical Center · R01 · FY2022 · CA
Dietary trans-vaccenic acid enhances anti-tumor immunity
$375,150Jing Chen · University Of Chicago · R01 · FY2023 · CA
Dietary trans-vaccenic acid enhances anti-tumor immunity
$375,150Jing Chen · University Of Chicago · R01 · FY2025 · CA
Core D: Long-term Follow-Up
$375,125Stephanie J Lee · Fred Hutchinson Cancer Research Center · P01 · FY2019 · CA
Hodgkin's Lymphoma Stem Cells
$375,115Richard Ambinder · Johns Hopkins University · P01 · FY2011 · CA
Overcoming primary and secondary resistance in wild-type BRAF melanoma
$375,106Andrew E Aplin · Wistar Institute · P01 · FY2019 · CA
Heterogeneity and molecular signatures of therapeutic T cells in allergic airwayinflammation.
$375,096Weishan Huang · Louisiana State Univ A&M Col Baton Rouge · R56 · FY2020 · AI
Structural Studies of a T cell Specific Tyrosine Kinase
$375,058Amy H Andreotti · Iowa State University · R01 · FY2014 · AI
TOWARD AN UNDERSTANDING OF CLL PROGRESSION
$375,020Carlo M Croce · Ohio State University · R01 · FY2012 · CA